Biblio

Journal Article
SanMiguel JM, Young K, Trowbridge JJ. Hand in Hand: Intrinsic and Extrinsic Drivers of Aging and Clonal Hematopoiesis. Exp Hematol. 2020.
Le LV, Mkrtschjan MA, Russell B, Desai TA. Hang on tight: reprogramming the cell with microstructural cues. Biomed Microdevices. 2019;21(2):43.
Yoshimatsu M, Kawashita Y, Soutome S, Murata M, Sawayama Y, Kurogi T, Nakao N, Miyazaki Y, Umeda M, Ukai T. Hangeshashinto for prevention of oral mucositis in patients undergoing hematopoietic stem cell transplantation: a randomized phase II study. Support Care Cancer. 2023;31(12):707.
Yin X, Liu X, Pan Y-T, Walsh KA, Yang H. Hanoi Tower-like Multilayered Ultrathin Palladium Nanosheets. Nano Lett. 2014.
Chen J, Xiao J, Han X, Sima X, Guo W. An HA/PEEK scaffold with modified crystallinity via 3D-bioprinting for multiple applications in hard tissue engineering. Biomed Mater. 2023.
Wiedmann L, Rigotti FDe Angelis, Vaquero-Siguero N, Donato E, Espinet E, Moll I, Alsina-Sanchis E, Bohnenberger H, Fernandez-Florido E, Mülfarth R, et al. HAPLN1 potentiates peritoneal metastasis in pancreatic cancer. Nat Commun. 2023;14(1):2353.
Hao D-J, Qin Y, Zhou S-J, Dong B-H, Yang J-S, Zou P, Wang L-P, Zhao Y-T. Hapln1 promotes dedifferentiation and proliferation of iPSC-derived cardiomyocytes by promoting versican-based GDF11 trapping. J Pharm Anal. 2024;14(3):335-347.
Mahony CB, Cacialli P, Pasche C, Monteiro R, Savvides SN, Bertrand JY. Hapln1b, a central organizer of the extracellular matrix, modulates kit signalling to control developmental haematopoiesis. Blood Adv. 2021.
Kwon M, Bautista G, Balsalobre P, Sánchez-Ortega I, Serrano D, Anguita J, Buño I, Fores R, Regidor C, Marco JAGarcía, et al. Haplo-Cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders. Biol Blood Marrow Transplant. 2014.
Yuan F, Li G, Li M, Wei X, Fu Y. Haplo-Cord transplantation with 8mg/kg anti-thymocyte globulin as graft-versus-host disease prophylaxis compared to haploidentical transplantation with 10mg/kg anti-thymocyte globulin in the treatment of acute leukemia. Transplant Cell Ther. 2023.
Feng J, Hsu P-F, Esteva E, Labella R, Wang Y, Khodadadi-Jamayran A, Pucella JNicholas, Liu CZ, Arbini AA, Tsirigos A, et al. Haplodeficiency of the 9p21 Tumor Suppressor Locus Causes Myeloid Disorders Driven by the Bone Marrow Microenvironment. Blood. 2023.
Wutz A. Haploid animal cells. Development. 2014;141(7):1423-1426.
Aizawa E, Kaufmann C, Sting S, Boigner S, Freimann R, Di Minin G, Wutz A. Haploid mouse germ cell precursors from embryonic stem cells reveal Xist activation from a single X chromosome. Stem Cell Reports. 2021.
Pierini A, Ruggeri L, Carotti A, Falzetti F, Saldi S, Terenzi A, Zucchetti C, Ingrosso G, Zei T, Ostini RIacucci, et al. Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia. Blood Adv. 2021;5(5):1199-1208.
Lin C-H, Su Y-J, Hsu C-Y, Wang P-N, Teng C-LJerry. Haploidentical allogeneic hematopoietic stem cell transplantation increases the risk of cytomegalovirus infection in adult patients with acute leukemia. Transpl Infect Dis. 2019:e13096.
Gomez-Arteaga A, Orfali N, Pasciolla M, Baptiste A, Guindine I, Hsu J, Lin J, Mayer SA, Phillips AA, Shore TB, et al. Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD). Bone Marrow Transplant. 2023.
Baena JC, Rosales MC, Estacio M, Hidalgo A, Arrieta E, Jaramillo FJ, Manzi E, Parra-Lara LGabriel, Rosales JD. Haploidentical and Matched Sibling Transplantation for Acute Myeloid Leukemia: A Hospital-Based Study. J Hematol. 2023;12(6):255-267.
Wang Y-C, Lai C-L, Chen T-C, Gau J-P, Teng C-LJerry. Haploidentical and matched unrelated donor allogeneic hematopoietic stem cell transplantation offer similar survival outcomes for acute leukemia. Cancer Rep (Hoboken). 2024;7(4):e2060.
Esteves I, Bonfim C, Pasquini R, Funke V, Pereira NF, Rocha V, Novis Y, Arrais C, Colturato V, de Souza MP, et al. Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study. Bone Marrow Transplant. 2015.
DeZern AE, Zahurak ML, Symons HJ, Cooke KR, Rosner GL, Gladstone DE, Huff CAnn, Swinnen LJ, Imus P, Borrello I, et al. Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide. Blood Adv. 2020;4(8):1770-1779.
Pury S, Orozco MLópez, Pichichero G, Sasia LV, Morell D, Álvarez MS, Basquiera AL, Mas ME, Salvucci K. Haploidentical bone marrow transplantation in a pediatric patient with Wiskott-Aldrich syndrome. A case report. Arch Argent Pediatr. 2023:e202310061.
Slatter M, Nademi Z, T Leahy R, MorilloGutierrez B, Dunn J, Barge D, Skinner R, Ryan C, Hambleton S, Abinun M, et al. Haploidentical CD3 TCRαβ and CD19-depleted second stem cell transplant for steroid-resistant acute skin graft versus host disease. J Allergy Clin Immunol. 2016.
Ma X, Chen Y, Liu Y, Cheng TT, Chen X, Zeng C, Hua J, Wang SY, Xu YJ. [Haploidentical donor peripheral blood stem cell transplantation using third-party cord blood compared with matched unrelated donor transplantation for patients with hematologic malignancies]. Zhonghua Xue Ye Xue Za Zhi. 2024;45(2):141-147.
Tanase A, Tomuleasa C, Marculescu A, Bardas A, Colita A, Orban C, Ciurea SOctavian. Haploidentical Donors: Can Faster Transplantation Be Life-Saving for Patients with Advanced Disease?. Acta Haematol. 2016;135(4):211-216.
Arcese W, Picardi A, Santarone S, De Angelis G, Cerretti R, Cudillo L, Pennese E, Bavaro P, Olioso P, Dentamaro T, et al. Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update. Bone Marrow Transplant. 2015;50(S2):S24-S30.

Pages